Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FREEPORT-MCMORAN INC Director's Dealing 2021

Feb 17, 2021

30000_dirs_2021-02-17_e11e9bdf-1669-42f9-b335-e34cb86fa2c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FREEPORT-MCMORAN INC (FCX)
CIK: 0000831259
Period of Report: 2021-02-12

Reporting Person: WHITMIRE C DONALD JR (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-12 Common Stock M 10000 $18.74 Acquired 85492 Direct
2021-02-12 Common Stock M 1620 $24.08 Acquired 87112 Direct
2021-02-12 Common Stock M 10000 $11.87 Acquired 97112 Direct
2021-02-12 Common Stock M 10000 $15.52 Acquired 107112 Direct
2021-02-12 Common Stock M 15000 $18.98 Acquired 122112 Direct
2021-02-12 Common Stock M 1620 $29.47 Acquired 123732 Direct
2021-02-12 Common Stock S 48240 $30.8373 Disposed 75492 Direct
2021-02-15 Common Stock F 2655 $31.23 Disposed 72837 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-12 Options (right to buy) $29.47 M 1620 Disposed 2023-01-28 Common Stock (1620) Direct
2021-02-12 Options (Right to Buy) $11.87 M 10000 Disposed 2029-02-05 Common Stock (10000) Direct
2021-02-12 Options (Right to Buy) $18.74 M 10000 Disposed 2028-02-06 Common Stock (10000) Direct
2021-02-12 Options (Right to Buy) $15.52 M 10000 Disposed 2027-02-07 Common Stock (10000) Direct
2021-02-12 Options (right to buy) $18.98 M 15000 Disposed 2025-02-03 Common Stock (15000) Direct
2021-02-12 Options (right to buy) $24.08 M 1620 Disposed 2022-02-06 Common Stock (1620) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1959 Indirect
Common Stock 4785 Indirect
Common Stock 4785 Indirect

Footnotes

F1: Based on plan statement as of December 31, 2020.

F2: 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof.

F3: 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof.

F4: The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $30.62 - $30.99. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: Amount beneficially owned following the reported transactions includes 44,999 Common Stock Restricted Stock Units.

F6: Shares withheld to cover the taxes due upon the vesting of 10,000 Common Stock Restricted Stock Units